4 of 4 samples (functions and classes) lifted from this paper's linked repositories executed on a synthesized input in Syntology's jail (0 of them constructed an object rather than computing a result; 1 honoured the contract we drafted, 1 violated it and 0 have no contract verdict; 2 failures of our instrument; 0 no recorded run), measured 2026-11-21; repository links from the Papers with Code archive attributed under CC BY-SA, no affiliation; bodies inline only under a permissive licence as GitHub detects it. Not a reproduction of the paper's results.
"Ran" means the function executed on a synthesized input and returned a value. It is not a reproduction of the paper's results. This record, dated, as JSON: /api/ran/2004.07229.json · badge: /api/ran/2004.07229.svg
Each repository's role is a label: a classifier's output recorded on the link, or, where no role is recorded, what the Papers with Code archive marked. The line under it names its basis. Neither says who wrote the code.
| Repository | Role | Ran |
|---|---|---|
| Barabasi-Lab/COVID-19 | canonical (classifier label) classifier basis: classifier_2025 |
4 ran · 0 no recorded run |
| Function | Status | Where it lives |
|---|---|---|
| js_cal | Ran ran, violated the contract we drafted |
Barabasi-Lab/COVID-19/03_1_DR_Diff_matrix_generator.py pointer only (licence: NONE) · get_code("5dfa48abda306425") How it ranThe body of this sample is withheld: GitHub detected no licence in this paper's repository, Barabasi-Lab/COVID-19 when it was checked. The setup block that called it is withheld with it, because it is written against that body. source_path and origin say where the code lives, to read under the repository's own terms. A run is recorded. |
| kl_divergence | Ran ran, honoured the contract we drafted |
Barabasi-Lab/COVID-19/03_1_DR_Diff_matrix_generator.py pointer only (licence: NONE) · get_code("08d9e207afab098a") How it ranThe body of this sample is withheld: GitHub detected no licence in this paper's repository, Barabasi-Lab/COVID-19 when it was checked. The setup block that called it is withheld with it, because it is written against that body. source_path and origin say where the code lives, to read under the repository's own terms. A run is recorded. |
| kl_divergence_matrix | Ran ran; our contract draft was wrong, not the code |
Barabasi-Lab/COVID-19/03_1_DR_Diff_matrix_generator.py pointer only (licence: NONE) · get_code("11426d26dfb99e99") How it ranThe body of this sample is withheld: GitHub detected no licence in this paper's repository, Barabasi-Lab/COVID-19 when it was checked. The setup block that called it is withheld with it, because it is written against that body. source_path and origin say where the code lives, to read under the repository's own terms. A run is recorded. |
| load_embedding_vectors | Ran ran; our contract draft was wrong, not the code |
Barabasi-Lab/COVID-19/02_DR_AI.py pointer only (licence: NONE) · get_code("1847d3681f3c08f7") How it ranThe body of this sample is withheld: GitHub detected no licence in this paper's repository, Barabasi-Lab/COVID-19 when it was checked. The setup block that called it is withheld with it, because it is written against that body. source_path and origin say where the code lives, to read under the repository's own terms. A run is recorded. |
Of 4 samples lifted from this paper's linked repositories, 4 carry a function identity and 0 do not. Of the 4 distinct functions with an identity, 0 are also present in other papers whose code we hold (0 with at least one paper dated earlier, 0 the same month, 0 later) and 4 are only here among the 52,977 papers whose code Syntology holds (as of 2026-09-26).
Only here means: among the 52,977 papers whose code Syntology holds (51,887 with lifted samples, 1,090 through their assemblies only), as of 2026-09-26, no other paper's lifted samples or current assembly bricks contain an identical function body after normalisation.
Presence, not direction: an identical function body in two papers' repositories does not say who wrote it, which came from which, or that either paper's method rests on it. Matching is exact after normalisation, so a renamed or edited function is not matched. Dates are when papers appeared, not when code was written. Only .py files the harvester lifted are covered; notebooks are not read. A new-style arXiv id YYMM.NNNN dates a paper to the month 20YY-MM; otherwise Paper.year dates it to the year; otherwise it is undated. Dates are when the paper appeared, not when the code was written. Read 2026-11-21.
Some links come from the archived Papers with Code dataset (CC BY-SA 4.0): attribution and licence.
The current pandemic has highlighted the need for methodologies that can quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections. In the past decade, network medicine has developed and validated multiple predictive algorithms for drug repurposing, exploiting the sub-cellular network-based relationship between a drug's targets and disease genes. Here, we deployed algorithms relying on artificial intelligence, network diffusion, and network proximity, tasking each of them to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. To test the predictions, we used as ground truth 918 drugs that had been experimentally screened in VeroE6 cells, and the list of drugs under clinical trial, that capture the medical community's assessment of drugs with potential COVID-19 efficacy. We find that while most algorithms offer predictive power for these ground truth data, no single method offers consistently reliable outcomes across all datasets and metrics. This prompted us to develop a multimodal approach that fuses the predictions of all algorithms, showing that a consensus among the different predictive methods consistently exceeds the performance of the best individual pipelines. We find that 76 of the 77 drugs that successfully reduced viral infection do not bind the proteins targeted by SARS-CoV-2, indicating that these drugs rely on network-based actions that cannot be identified using docking-based strategies. These advances offer a methodological pathway to identify repurposable drugs for future pathogens and neglected diseases underserved by the costs and extended timeline of de novo drug development.
The same record, over MCP at https://syntology.ai/mcp:
get_harvested_code_for_paper("2004.07229")
get_code_for_paper("2004.07229")
have("2004.07229")
The run record, dated, one paper per request, free:
curl https://syntology.ai/api/ran/2004.07229.json
A badge for a README (the split and the date, never a ratio):
[](https://syntology.ai/paper/2004.07229)
Connect an agent — have() is free.